Beijing Scitop Bio Tech Co Ltd (300858) — Cash Flow-to-Debt Ratio
Beijing Scitop Bio Tech Co Ltd (300858) has a Cash Flow-to-Debt Ratio of 0.39x as of September 2025, meaning its operating cash flow of CN¥44.72 Million could theoretically repay 0% of its total liabilities (CN¥114.58 Million) in one year. See 300858 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Beijing Scitop Bio Tech Co Ltd Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Beijing Scitop Bio Tech Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see 300858 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Beijing Scitop Bio Tech Co Ltd (2015–2025)
Year-by-year debt coverage analysis for Beijing Scitop Bio Tech Co Ltd. Check Beijing Scitop Bio Tech Co Ltd (300858) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.70x | CN¥123.44 Million | CN¥176.08 Million | ▼ -37.8% |
| 2024 | 1.13x | CN¥142.11 Million | CN¥126.03 Million | ▼ -19.0% |
| 2023 | 1.39x | CN¥107.27 Million | CN¥77.10 Million | ▼ -11.9% |
| 2022 | 1.58x | CN¥148.46 Million | CN¥93.99 Million | ▲ +5.0% |
| 2021 | 1.50x | CN¥110.27 Million | CN¥73.33 Million | ▲ +50.3% |
| 2020 | 1.00x | CN¥66.67 Million | CN¥66.66 Million | ▼ -32.7% |
| 2019 | 1.49x | CN¥98.27 Million | CN¥66.14 Million | ▲ +19.3% |
| 2018 | 1.25x | CN¥89.55 Million | CN¥71.91 Million | ▼ -16.5% |
| 2017 | 1.49x | CN¥84.00 Million | CN¥56.30 Million | ▲ +226.8% |
| 2016 | 0.46x | CN¥32.73 Million | CN¥71.69 Million | ▲ +2142.4% |
| 2015 | 0.02x | CN¥2.69 Million | CN¥131.89 Million | — |